Using the ATC/DDD to Monitor Antibiotic Use at Lower Primary Care Facilities in Southwestern Uganda
Feasibility of Using the Chemical Classification System/Defined Daily Doses Tool to Monitor Antibiotic Use at Primary Healthcare Facilities in Southwestern Uganda
1 other identifier
interventional
1,406
1 country
1
Brief Summary
This is a non blinded two arm cluster randomized control trial, aimed at assessing the feasibility of using the Anatomical Therapeutic Chemical Classification/define Daily Doses system tool to monitor antibiotic use at lower primary levels of care in Uganda.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 19, 2021
CompletedStudy Start
First participant enrolled
March 1, 2021
CompletedFirst Posted
Study publicly available on registry
March 4, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2021
CompletedMarch 4, 2021
February 1, 2021
7 months
February 19, 2021
March 1, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Trends in antibiotic utilization for both the intervention and non intervention arms
Computation of antibiotic utilization parameters across the different facility levels will be done using the latest version of the ATC/DDD tool. Antibiotic use by clinical condition data will be analyzed using working diagnoses that will be classified into diagnostic groups using the latest version of the International Classification of Diseases, Clinical Modification (ICD-10-CM) diagnosis codes as a guide. Findings of both arms will be compared.
3 months
Study Arms (2)
ATC/DDD arm
EXPERIMENTALThe intervention is the introduction of the ATC/DDD including the training of healthcare workers on its importance and usage in monitoring antibiotic use. The unit of intervention will be a health facility. Antibiotic prescriptions and antibiotic utilization records for adult patients (in-patients and ambulatory) from the selected facilities will be enrolled in the study.
Control arm
NO INTERVENTIONThe health care workers will continue with standard practice. However, the research team will collect data on antibiotic prescriptions and antibiotic utilization for adult patients (in-patients and ambulatory) from the selected facilities. The data will be compared with that of the intervention arm.
Interventions
The intervention is the introduction of the ATC/DDD including the training on its importance and usage in monitoring antibiotic use at a given primary care facility.
Eligibility Criteria
You may qualify if:
- Health facility: The facility will be government owned that receives antibiotics from National Medical Stores using the current schedule and has no ongoing antibiotic use related intervention study.
- Prescribers: Male and female prescribers at primary care facilities in the selected districts of Mbarara, Bushenyi and Kasese will be recruited. Prescribers with an experience of at least 3 months in antibiotic prescribing and inventory at these facilities will be included in the study. These shall be identified through the in-charges of the respective facilities.
- Patients: New male and female adult patients (18 years and above) receiving antibiotic medication will be enrolled.
- Antibiotic utilization records: Antibiotic prescriptions and administration charts for new patients at selected health facilities.
You may not qualify if:
- Patients: Those who are too sick to cooperate
- Prescriptions: Ineligible prescriptions and the prescriber cannot be reached for clarifications.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hanifah Nantongo
Mbarara, Uganda
Study Officials
- STUDY DIRECTOR
Jackson Mukonzo, PhD
Makerere University
- STUDY DIRECTOR
Vincent Batwala, PhD
Mbarara University of Science and Technology
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Being a feasibility study that will use patient records, no blinding will be done.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 19, 2021
First Posted
March 4, 2021
Study Start
March 1, 2021
Primary Completion
October 1, 2021
Study Completion
November 1, 2021
Last Updated
March 4, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share
I do not intend to share the data